Hepatitis C viremia patterns in incident hepatitis C infection and one year later in 150 prospectively tested persons who inject drugs

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Alanko Blomé, Marianne ^a   Björkman, Per ^a   Molnegren, Vilma ^a   Höglund, Peter ^b   Widell, Anders ^a  

^a LUND UNIVERSITY   (Sweden)

^b Research and Development   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DIAMORPHINE; HEPATITIS B SURFACE ANTIGEN; VIRUS RNA; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; COHORT ANALYSIS; DRUG ABUSE; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HIV TEST; HUMAN; HUMAN CELL; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MICROBIAL KINETICS; NONHUMAN; PEOPLE WHO INJECT DRUG; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEROCONVERSION; SEX DIFFERENCE; SWEDEN; VIRAL CLEARANCE; VIREMIA; VIRUS DETECTION; VIRUS LOAD; BLOOD; EPIDEMIOLOGY; GENETICS; GENOTYPE; HEPACIVIRUS; MIDDLE AGED; PREVENTIVE HEALTH SERVICE; SUBSTANCE ABUSE; TIME; VIROLOGY; YOUNG ADULT;

ADULT; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; NEEDLE-EXCHANGE PROGRAMS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RNA, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS; SWEDEN; TIME FACTORS; VIRAL LOAD; VIREMIA; YOUNG ADULT;

EID: 84901366170     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097022     Document Type: Article

References (38)

1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST (2013) Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 57: 1333-42.
2. Chemaitelly H, Abu-Raddad LJ, Miller FD (2013) An apparent lack of epidemiologic association between hepatitis C virus knowledge and the prevalence of hepatitis C infection in a national survey in Egypt. PloS One 8: e69803
3. Duberg A, Janzon R, Back E, Ekdahl K, Blaxhult A (2008) The epidemiology of hepatitis C virus infection in Sweden. Euro Surveill 13: pii = 18882
4. Alberti A, Chemello L, Benvegnu L (1999) Natural history of hepatitis C. J Hepatol Suppl 1: 17-24. (Pubitemid 30002686)
5. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, et al (2011) Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 378: 571-83.
6. Hajarizadeh B, Grebely J, Dore GJ (2012) Case definitions for acute hepatitis C virus infection: a systematic review. J Hepatol 57: 1349-60.
7. Hatzakis A, Wait S, Bruix J, Buti M, Carballo M, et al (2011) The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference. J Viral Hepat Suppl 1: 1-16.
8. Miller ER, Bi P, Ryan P (2009) Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors. Int J Infect Dis 13: 201-8.
9. Lee KC, Lim WW, Lee SS (2008) High prevalence of HCV in a cohort of injectors on methadone substitution treatment. J Clin Virol 41: 297-300.
10. Turner KM, Hutchinson S, Vickerman P, Hope V, Craine N, et al (2011) The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction 106: 1978-88.
11. McGovern BH, Birch CE, Bowen MJ, Reyor LL, Nagami EH, et al (2009) Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria. Clin Infect Dis 49: 1051-60.
12. Maheshwari A, Ray S, Thuluvath PJ (2008) Acute hepatitis C. Lancet 372: 321-32. (Pubitemid 352020441)
13. Wawrzynowicz-Syczewska M, Kubicka J, Lewandowski Z, Boron-Kaczmarska A, Radkowski M (2004) Natural history of acute symptomatic hepatitis type C. Infection 32: 138-43. (Pubitemid 38757017)
14. Fabris P, Fleming VM, Giordani MT, Barnes E (2008) Acute hepatitis C: clinical aspects, diagnosis, and outcome of acute HCV infection. Curr Pharm Des 14: 1661-5. (Pubitemid 351998590)
15. Aberle JH, Formann E, Steindl-Munda P, Weseslindtner L, Gurguta C, et al (2006) Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection. J Clin Virol 36: 24-31. (Pubitemid 44360574)
16. Micallef JM, Kaldor JM, Dore GJ (2006). Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 13: 34-41.
17. Doyle JS, Hellard ME, Thompson AJ (2012) The role of viral and host genetics in natural history and treatment of chronic HCV infection. Best Pract Res Clin Gastroenterol 26: 413-27.
18. Liu L, Fisher BE, Thomas DL, Cox AL, Ray SC (2012) Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution. Hepatology 55: 1684-91.
19. Amini M, Poustchi H (2012) Hepatitis C virus spontaneous clearance: immunology and genetic variance. Viral Immunol 25: 241-8.
20. de Almeida BS, Silva GM, da Silva PM, Perez Rde M, Figueiredo FA, et al (2011) Ethnicity and route of HCV infection can influence the associations of HLA with viral clearance in an ethnically heterogeneous population. J Viral Hepat 18: 692-9.
21. Soriano V, Mocroft A, Rockstroh J, Ledergerber B, Knysz B, et al (2008) Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe. J Infect Dis 198: 1337-44.
22. Dale CH, Burns P, McCutcheon M, Hernandez-Alejandro R, Marotta PJ (2009) Spontaneous clearance of hepatitis C after liver and renal transplantation. Can J Gastroenterol 23: 265-7.
23. Gutierrez-Moreno M, Bernal-Bellido C, Suarez-Artacho G, Alamo-Martinez JM, Marin-Gomez LM, et al (2012) Spontaneous clearance of HCV in HIV-hepatitis C virus coinfected liver transplant patients: prospective study. Transplant Proc 44: 2100-2.
24. Olsson B, Adamsson-Wahren C, Byqvist S (2001) Det tunga narkotikamissbrukets omfattning i Sverige 1998/The extent of heavy drug abuse in Sweden 1998. The MAX-project, Centralförbundet for alkohol- och narkotikaupplysning (CAN) 3: 61
25. Blome MA, Bjorkman P, Flamholc L, Jacobsson H, Molnegren V, et al (2011) Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program. J Viral Hepat 18: 831-9.
26. Abdel-Hamid M, El-Daly M, Molnegren V, El-Kafrawy S, Abdel-Latif S, et al (2007) Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma. J Gen Virol 88: 1526-31. (Pubitemid 46723235)
27. Widell A, Molnegren V, Pieksma F, Calmann M, Peterson J, et al (2002) Detection of hepatitis C core antigen in serum or plasma as a marker of hepatitis C viraemia in the serological window-phase. Transfus Med 12: 107-13. (Pubitemid 34429222)
28. Page K, Hahn JA, Evans J, Shiboski S, Lum P, et al (2009) Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis 200: 1216-26.
29. Jauncey M, Micallef JM, Gilmour S, Amin J, White PA, et al (2004) Clearance of hepatitis C virus after newly acquired infection in injection drug users. J Infect Dis 190: 1270-4. (Pubitemid 39287753)
30. Mathei C, Buntinx F, Van Damme P (2001) Is the prevalence of hepatitis C virus (HCV) RNA in anti-HCV-positive injection drug users positively correlated with age? J Infect Dis 184: 659-60. (Pubitemid 32783563)
31. Cochrane A, Searle B, Hardie A, Robertson R, Delahooke, et al (2002) A genetic analysis of hepatitis C virus transmission between injection drug users. J Infect Dis 186: 1212-21. (Pubitemid 35192999)
32. Mansson AS, Moestrup T, Nordenfelt E, Widell A (2000) Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program. Scand J Infect Dis 32: 253-8. (Pubitemid 30599214)
33. Des Jarlais DC, Perlis T, Arasteh K, Torian LV, Hagan H, et al (2005) Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001. AIDS Suppl 3: S20-5. (Pubitemid 41682165)
34. Page K, Osburn W, Evans J, Hahn JA, Lum P, et al. (2013) Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection. Clin Infect Dis 56: 405-13.
35. van de Laar TJ, Molenkamp R, van den Berg C, Schinkel J, Beld MG, et al (2009) Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam. J Hepatol 51: 667-74.
36. Marco A, Esteban JI, Sole C, da Silva A, Ortiz J, et al (2013) Hepatitis C virus reinfection among prisoners with sustained virological response after treatment for chronic hepatitis C. J Hepatol 59: 45-51.
37. Dalgard O, Bjoro K, Hellum K, Myrvang B, Skaug K, et al (2002) Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up. Eur Addict Res 8: 45-9. (Pubitemid 34701984)
38. Micallef JM, Macdonald V, Jauncey M, Amin J, Rawlinson W, et al (2007) High incidence of hepatitis C virus reinfection within a cohort of injecting drug users. J Viral Hepat 14: 413-8. (Pubitemid 46744050)